Use access key #2 to skip to page content.
$4.25 0.64 (17.73%)
10/10/2008 4:00 PM

Repligen Corp (RGEN)

CAPS Rating:
*****

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

View All Commentary (RGEN)

Recs

0

Avatar darksider389 (< 20) Submitted: 6/22/08 1:07 PM : Outperform Start Price: $4.90 RGEN Score: 19.73

Buy back.

Report this Post Replies: 0 | Reply

Featured Broker Partners